# Effects of Oral Glutamine Supplementation on Insulin Resistance and Functional Intestinal Disorders in Obese Patients.

> **NCT04883515** · NA · RECRUITING · sponsor: **University Hospital, Rouen** · enrollment: 110 (estimated)

## Conditions studied

- Obesity
- Insulin Resistance

## Interventions

- **DIETARY_SUPPLEMENT:** Oral glutamine supplementation
- **DIETARY_SUPPLEMENT:** Oral protein powder supplementation
- **PROCEDURE:** Insulin-resistance evaluation
- **PROCEDURE:** Functional intestinal disorders evaluation

## Key facts

- **NCT ID:** NCT04883515
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-01
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04883515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04883515, "Effects of Oral Glutamine Supplementation on Insulin Resistance and Functional Intestinal Disorders in Obese Patients.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04883515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*